Andreas Kluge
Patrimonio netto: 194 M $ in data 31/05/2026
Patrimonio netto: 194 M $ in data 31/05/2026
Andreas Kluge founded Therapeia GmbH & Co. Kg in 2007, where he is working as Chief Executive Officer from 2007, ABX-CRO advanced pharmaceutical services in 2002, where he is working as General Manager & Medical Director from 2002, ABX advanced biochemical compounds GmbH in 1996, where he worked as Chief Executive Officer from 1996 to 2002, and Telix Pharmaceuticals Ltd. in 2015, where he worked as Non-Executive Director from 2020 to 2024.
Dr. Kluge received his doctorate degree from Freie Universität Berlin.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/02/2026 | 20.675.000 ( 6,09% ) | 194 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Provides diagnostic and therapeutic radiopharmaceuticals | Amministratore Delegato | 01/01/2007 |
ABX-CRO advanced pharmaceutical services | Fondatore | 01/08/2002 |
| Società | Posizione | Fine |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Fondatore | 17/10/2024 |
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Manufactures chemicals for nuclear medicine applications | Amministratore Delegato | 01/07/2002 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Manufactures chemicals for nuclear medicine applications | Process Industries |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Provides diagnostic and therapeutic radiopharmaceuticals | Health Technology |
ABX-CRO advanced pharmaceutical services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale